Stock CLXT CIBUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cibus, Inc. Nasdaq

Equities

CLXT

US17166A1016

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-24 EDT 		5-day change 1st Jan Change
9.56 USD -4.40% Intraday chart for Cibus, Inc. +1.81% -51.32%
05-30 Cibus? White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola CI
05-09 Cibus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Cibus, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd31da8e922e.q66Oomoz_r91v3z7HhO032DGYqrLDAGg25gTEIaIL9E.8-S_8Sx_keUW_Q6qVlvmlVOWUeGOf2yRlvZ5YsylS4fg-fbWIniO9kDPTA~e0f10e746c48d0455b1b59d095fbbba5

Analyst Recommendations on Cibus, Inc.

HC Wainwright Downgrades Calyxt to Neutral From Buy MT
ETF Preview: ETFs Mixed, Futures Slightly Higher Pre-Bell After Fed Rate Increase, Jobless Claims MT
Canaccord Genuity Adjusts Calyxt's Price Target to $4 From $6, Keeps Buy Rating MT
Roth Capital Starts Calyxt at Buy With $10 Price Target MT
CALYXT : Berenberg Bank Initiates Coverage on Calyxt With Buy Rating, $9 Price Target MT
CALYXT : HC Wainwright Starts Calyxt at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
9.56 USD
Average target price
23 USD
Spread / Average Target
+140.59%
High Price Target
25 USD
Spread / Highest target
+161.51%
Low Price Target
19 USD
Spread / Lowest Target
+98.74%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cibus, Inc.

HC Wainwright
Canaccord Genuity
Roth Capital Partners

Ratings for Cibus, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CLXT Stock
  4. CLXT Stock
  5. Consensus Cibus, Inc.